LONDON--(BUSINESS WIRE)--
Ap19 - Amendment to Purchase
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 19 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
6,219,473 |
2.47% |
313,046 |
0.12% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
223,085 |
0.09% |
5,435,337 |
2.16% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
6,442,558 |
2.56% |
5,748,383 |
2.28% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 130 |
10.6994 GBP |
| Purchase | 518 |
10.7100 GBP |
| Purchase | 825 |
10.7050 GBP |
| Purchase | 3,681 |
10.7212 GBP |
| Purchase | 5,254 |
10.7229 GBP |
| Purchase | 6,192 |
10.7200 GBP |
| Purchase | 6,568 |
10.7204 GBP |
| Purchase | 6,575 |
10.7055 GBP |
| Purchase | 9,364 |
10.7120 GBP |
| Purchase | 24,471 |
10.7000 GBP |
| Purchase | 26,549 |
10.7267 GBP |
| Purchase | 36,669 |
10.7183 GBP |
| Purchase | 250,000 |
10.7053 GBP |
| Purchase | 250,000 |
10.7253 GBP |
| Sale | 763 |
10.7044 GBP |
| Sale | 916 |
10.7088 GBP |
| Sale | 950 |
10.7168 GBP |
| Sale | 974 |
10.7179 GBP |
| Sale | 1,185 |
10.7011 GBP |
| Sale | 1,603 |
10.7050 GBP |
| Sale | 1,622 |
10.7136 GBP |
| Sale | 2,231 |
10.7277 GBP |
| Sale | 3,971 |
10.7100 GBP |
| Sale | 5,935 |
10.7000 GBP |
| Sale | 6,072 |
10.7033 GBP |
| Sale | 9,546 |
10.7300 GBP |
| Sale | 15,655 |
10.7257 GBP |
| Sale | 25,000 |
10.7200 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction |
Number of relevant securities |
Price per |
|
|
unit |
|
| CFD | Long |
763 |
10.7044 GBP |
| SWAP | Long |
6,664 |
10.7073 GBP |
| SWAP | Long |
12,618 |
10.7046 GBP |
| SWAP | Short |
2,715 |
10.7094 GBP |
| SWAP | Short |
4,291 |
10.7037 GBP |
| CFD | Short |
6,575 |
10.7055 GBP |
| SWAP | Short |
6,916 |
10.7025 GBP |
| SWAP | Short |
22,328 |
10.7000 GBP |
| SWAP | Short |
31,005 |
10.7225 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 21 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|